AgeX Therapeutics, Inc. (AGE) Financials

AGE Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 12.2 million 39.9 million
2023-06-30 12.3 million 34.6 million
2023-03-31 12.5 million 32.5 million
2022-12-31 3.2 million 20.6 million

AGE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.9 million 40000
2023-06-30 -2.0 million 35000
2023-03-31 -1.9 million 70000
2022-12-31 -1.3 million 114000

AGE Net Income

No data available :(

AGE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 397000 - -
2023-06-30 261000 10.1 million -
2023-03-31 280000 10.0 million -
2022-12-31 645000 10.5 million -

AGE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 38.0 million
2023-06-30 38.0 million
2023-03-31 38.0 million
2022-12-31 37.9 million

AGE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 218000 2.2 million -
2023-06-30 - 160000 1.7 million -
2023-03-31 - 174000 2.0 million -
2022-12-31 - 208000 1.6 million -

AGE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 46000 33000
2023-06-30 9000 5000
2023-03-31 10000 1000
2022-12-31 8000 1000

AGE

Price: $11.10

52 week price:
0.31
35.20

Earnings Per Share: -0.38 USD

P/E Ratio: -1.02

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 785

Market Capitalization: 33.2 million

Links: